Abstract: A vehicle display device includes a projection device including a light-transmitting image display unit displaying an image, a light source emitting light to the image display unit from a back surface side or a front surface side, and a light-shielding cover disposed on a front surface of the image display unit and including an opening. The projection device projects an image onto a reflection unit disposed in front of an occupant in a vehicle. When the projection device is viewed from the front surface side, a shape of the opening is a shape similar to a shape of an image display region in the image display unit, and the opening is separated from an outer edge of the image display region and surrounds the image display region.

Abstract: To provide prepreg having high thermostability and a molded body (fiber reinforced composite) obtained from the prepreg, the prepreg is formed by impregnating a reinforced fiber having an elastic modulus of 100 to 900 GPa with an epoxy resin composition including the following Components A to D so as to have a resin content within a range of 25 to 50 mass %: Component A: an epoxy resin having an oxazolidone ring structure in a molecule thereof; Component B: an epoxy resin that is liquid at 30° C.; Component C: a diblock copolymer having a B-M structure, wherein M is a block including at least 50 mass % of methyl methacrylate, B is a block immiscible with the epoxy resins and the block M, a glass transition temperature of the block B being 20° C. or lower; and Component D: dicyandiamide, or an amine curing agent that is a derivative of dicyandiamide.

Abstract: There is provided a scanning projector transmissive screen having a first surface on which a microlens array is formed, and a second surface formed into a single lens shape.

Abstract: A head-up display device displays information to a driver in a form of a virtual image by projecting display light onto a reflection member. The head-up display device includes a display device which displays a virtual image of a first display image in a first display plane by emitting display light including the first display image and which displays virtual images of a plurality of second display images in a plurality of second display planes by emitting display light beams including the plurality of second display images, respectively. The first display plane is substantially perpendicular to a reference plane. The second display planes are substantially perpendicular to the reference plane and are arranged in a front-rear direction of the driver in a layered manner, and in which the virtual images of the plurality of second display images are displayed so as to be arranged along the reference plane.

Abstract: There is provided a scanning projector transmissive screen having a first surface on which a microlens array is formed, and a second surface formed into a single lens shape.

Abstract: A display device for a vehicle includes an irradiation unit that projects, through an opening provided to an instrument panel, display light onto a windshield located above the opening; and a display panel that is disposed on an opening side surface extending from an opening peripheral part toward a lower part of the instrument panel and that displays information to a driver.

Abstract: Provided is a scanning projector screen which can suppress inhomogeneity of a beam diameter. The scanning projector screen has a screen surface that is curved in at least one direction.

Abstract: An object of the present invention is to provide a drug having the inhibitory activity on ENPP2 which is a different target from that of the existing drug, as a medicament useful in a urinary excretion disorder patient for whom the existing drug has the insufficient effect. The present invention provides a compound represented by the general formula (I): (wherein definition of each group is as defined in the description) having the ENPP2 inhibitory activity, a salt thereof or a solvate thereof or a prodrug thereof, and an agent for preventing or treating urinary excretion disorder and/or improving symptoms thereof, containing them as an active ingredient.

Abstract: An object of the present invention is to provide a drug having the inhibitory activity on ENPP2 which is a different target from that of the existing drug, as a medicament useful in a urinary excretion disorder patient for whom the existing drug has the insufficient effect. The present invention provides a compound represented by the general formula (I): (wherein definition of each group is as defined in the description) having the ENPP2 inhibitory activity, a salt thereof or a solvate thereof or a prodrug thereof, and an agent for preventing or treating urinary excretion disorder and/or improving symptoms thereof, containing them as an active ingredient.

Abstract: The present invention provides a compound having ALXR agonist activity. Specifically, the invention provides a compound having ALXR agonist activity represented by general formula (I) wherein all the symbols are as defined in the specification, a salt thereof, a solvate thereof, or a prodrug thereof as well as an agent containing the same as an active ingredient for preventing and/or treating an ALXR-associated disease, such as an inflammatory bowel disease, an autoimmune disease, a chronic inflammatory disease, asthma, pulmonary fibrosis, atopic dermatitis, ischemia-reperfusion injury, myocardial infarction, or Alzheimer's disease.

Abstract: An object of the present invention is to provide a drug having the inhibitory activity on ENPP2 which is a different target from that of the existing drug, as a medicament useful in a urinary excretion disorder patient for whom the existing drug has the insufficient effect. The present invention provides a compound represented by the general formula (1): (wherein definition of each group is as defined in the description) having the ENPP2 inhibitory activity, a salt thereof or a solvate thereof or a prodrug thereof, and an agent for preventing or treating urinary excretion disorder and/or improving symptoms thereof, containing them as an active ingredient.

Abstract: There is provided a scanning projector transmissive screen having a first surface on which a microlens array is formed, and a second surface formed into a single lens shape.

Abstract: A head-up display device displays information to a driver in a form of a virtual image by projecting display light onto a reflection member. The head-up display device includes a display device which displays a virtual image of a first display image in a first display plane by emitting display light including the first display image and which displays virtual images of a plurality of second display images in a plurality of second display planes by emitting display light beams including the plurality of second display images, respectively. The first display plane is substantially perpendicular to a reference plane. The second display planes are substantially perpendicular to the reference plane and are arranged in a front-rear direction of the driver in a layered manner, and in which the virtual images of the plurality of second display images are displayed so as to be arranged along the reference plane.

Abstract: There is provided an HUD main body for displaying front display information formed as front virtual image on a line of sight of a passenger, lower display information formed as lower virtual image below the front virtual image, and upper display information formed as upper virtual image above the front virtual image. The lower virtual image and the upper virtual image are formed to be closer to the passenger as they are farther away from the front virtual image, or toward the lower side and the upper side, respectively.

Abstract: An object of the present invention is to provide a drug having the inhibitory activity on ENPP2 which is a different target from that of the existing drug, as a medicament useful in a urinary excretion disorder patient for whom the existing drug has the insufficient effect. The present invention provides a compound represented by the general formula (I): (wherein definition of each group is as defined in the description) having the ENPP2 inhibitory activity, a salt thereof or a solvate thereof or a prodrug thereof, and an agent for preventing or treating urinary excretion disorder and/or improving symptoms thereof, containing them as an active ingredient.

Abstract: There is provided a scanning projector transmissive screen having a first surface on which a microlens array is formed, and a second surface formed into a single lens shape.

Abstract: Provided is a scanning projector screen which can suppress inhomogeneity of a beam diameter. The scanning projector screen has a screen surface that is curved in at least one direction.

Abstract: An object of the present invention is to provide a drug having the inhibitory activity on ENPP2 which is a different target from that of the existing drug, as a medicament useful in a urinary excretion disorder patient for whom the existing drug has the insufficient effect. The present invention provides a compound represented by the general formula (I): (wherein definition of each group is as defined in the description) having the ENPP2 inhibitory activity, a salt thereof or a solvate thereof or a prodrug thereof, and an agent for preventing or treating urinary excretion disorder and/or improving symptoms thereof, containing them as an active ingredient.

Abstract: A display device includes: a concave mirror which is rotatable about a rotary shaft; and a stay formed of a base portion and a pair of raised wall portions mounted on the base portion in a raised manner and supporting the rotary shaft. The pair of raised wall portions is formed in an obliquely bent manner such that distal end portions of the raised wall portions extend away from each other thus allowing the raised wall portions easily deformable with a load applied in a raised direction.

Abstract: The present invention provides a compound having ALXR agonist activity. Specifically, the invention provides a compound having ALXR agonist activity represented by general formula (I) wherein all the symbols are as defined in the specification, a salt thereof, a solvate thereof, or a prodrug thereof as well as an agent containing the same as an active ingredient for preventing and/or treating an ALXR-associated disease, such as an inflammatory bowel disease, an autoimmune disease, a chronic inflammatory disease, asthma, pulmonary fibrosis, atopic dermatitis, ischemia-reperfusion injury, myocardial infarction, or Alzheimer's disease.